The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
GI Malignancies Debate 2022 | Highlights from the 2022 Great Debates & Updates in GI Malignancies Congress
Nitya Raj, MD, Memorial Sloan Kettering Cancer Center, New York, NY, provides an overview of her highlights from the 2022 Great Debates & Updates in Gastrointestinal Malignancies Congress, including advances in rare tumors such as gastrointestinal stromal tumours (GISTs) and appendix cancers. Dr Raj additionally discusses the role of circulating tumor DNA in colorectal cancer and optimizing treatment duration in stage II colon cancer. This interview took place virtually at the 2022 Great Debates & Updates in Gastrointestinal Malignancies Congress.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
